United States Protein Purification and Isolation Market Size, Share, and COVID-19 Impact Analysis, By Product (Instruments and Consumables), By Application (Drug Screening, Biomarker Discovery, Protein-Protein Interaction Studies, and Diagnostics), and United States Protein Purification and Isolation Market Insights, Industry Trend, Forecasts to 2035

United States Protein Purification and Isolation Market Insights Forecasts to 2035

• The United States Protein Purification and Isolation Market Size Was Estimated at USD 3.38 Billion in 2024
• The Market Size is Expected to Grow at a CAGR of Around 10.21% from 2025 to 2035
• The United States Protein Purification and Isolation Market Size is Expected to Reach USD 9.85 Billion by 2035

According to a research report published by Spherical Insights & Consulting,Tthe United States Protein Purification and Isolation Market Size is anticipated to reach USD 9.85 billion by 2035, growing at a CAGR of 10.21% from 2025 to 2035. The market is growing due to increasing demand for advancement in protein-based research, biopharmaceuticals, and the rising need for high-purity biologics in clinical and diagnostic applications.

Market Overview

The United States protein purification and isolation market involves tools and reagents used to extract and purify proteins for research, drug development, and biopharmaceutical production. The United States protein purification and isolation market is used to produce high-purity proteins for research, drug development, diagnostics, and biopharmaceuticals, as well as for industrial applications like enzymes and biotechnology products. The market is driven by increasing demand for biologics and vaccines, growing research in proteomics and personalized medicine, rising investment in biotechnology and pharmaceutical R&D, and the need for advanced purification technologies that ensure high-quality protein products.

Key opportunities in the United States protein purification and isolation market include growing demand for biopharmaceuticals, advancements in high-throughput purification technologies, expansion of proteomics and personalized medicine research, and increased use of proteins in industrial and biotech applications. In February 2026, NSF invests $100M in the National Quantum and Nanotechnology Research Infrastructure program, supporting 16 U.S. sites with advanced tools for biotechnology and protein characterization, boosting innovation, workforce development, and growth opportunities in the United States protein purification and isolation market.

Report Coverage

This research report categorizes the market for the United States protein purification and isolation market based on various segments and regions, and forecasts revenue growth and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the United States protein purification and isolation market. Recent market developments and competitive strategies, such as expansion, product launch, development, partnership, merger, and acquisition, have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the United States protein purification and isolation market.

Driving Factors

The United States protein purification and isolation market is driven by the growing investments in biomedical and pharmaceutical R&D, increasing demand for efficient, high-purity protein isolation, and the need for scalable purification processes that drive reagent and instrument consumption. Government initiatives, including NSF’s $100M National Quantum and Nanotechnology Research Infrastructure program supporting biotechnology and protein characterization, alongside private-sector efforts like Syncell’s $15M Series A funding, are accelerating technology adoption, innovation, and commercialization, reinforcing market growth and opportunities.

Restraining Factors

The United States protein purification and isolation market is mostly constrained by the high costs of instruments and reagents, complex purification processes, regulatory compliance challenges, limited scalability for certain proteins, and competition from alternative separation technologies.

Market Segmentation

The United States protein purification and isolation market share is classified into product and application.

• The consumables segment accounted for the largest revenue market share in 2024 and is expected to grow at a significant CAGR during the forecast period. 

The United States protein purification and isolation market is segmented by product into instruments and consumables. Among these, the consumables segment accounted for the largest revenue market share in 2024 and is expected to grow at a significant CAGR during the forecast period. This is due wide range of consumables, reagents, kits, resins, columns, and beads supporting consistent protein isolation across systems. Their routine use in research and biomanufacturing drives steady demand, while ongoing innovations increasingly focus on sustainability and regulatory compliance.

• The protein-protein interaction studies segment dominated the share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. 

The United States protein purification and isolation market is segmented by application into drug screening, biomarker discovery, protein-protein interaction studies, and diagnostics. Among these, the protein-protein interaction studies segment dominated the share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. This is due to their essential role in unraveling biological processes and enabling the development of targeted therapies. By analyzing protein interactions, researchers can reveal disease pathways, pinpoint potential drug targets, and create more precise treatments. This focus highlights a strategic commitment to advancing biomedical research and therapeutic innovation.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the United States protein purification and isolation market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborate analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Promega Corporation
• Norgen Biotek Corp.
• Takara Bio. Inc.
• Danaher
• Bio-Rad Laboratories, Inc.
• Agilent Technologies, Inc.
• Cube Biotech GmbH
• Thermo Fisher Scientific, Inc.
• Merck KGaA
• QIAGEN
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent Developments:

• In April 2025, QIAGEN announced that it is advancing plans to introduce three new sample preparation instruments by 2026 to strengthen and broaden its automated lab workflows, aiming to boost efficiency, sustainability, and scalability across a range of laboratory needs.

• In January 2025, Bio-Rad announced an expansion of its Foresight Pro chromatography column portfolio with a new 45 cm inner diameter option, offering GMP-ready, scalable solutions for downstream purification of biotherapeutics such as vaccines, antibodies, and recombinant proteins.

Market Segment

This study forecasts revenue at the United States, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the United States protein purification and isolation market based on the below-mentioned segments:

United States Protein Purification and Isolation Market, By Product

• Instruments
• Consumables

United States Protein Purification and Isolation Market, By Application

• Drug Screening
• Biomarker Discovery
• Protein-Protein Interaction Studies
• Diagnostics